Achieving tolerance modifies cancer susceptibility profiles in liver transplant recipients
Abstract Long‐term survival of transplant recipients is significantly impacted by malignancy. We aimed to determine whether calcineurin inhibitor (CNI)‐treated recipients converted to and weaned off molecular target of rapamycin inhibitor (mTOR‐I) therapy have favorable changes in their molecular pr...
Main Authors: | Mamatha Bhat, Elisa Pasini, Preya Patel, Jeffrey Yu, Cristina Baciu, Sunil M. Kurian, Josh Levitsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-02-01
|
Series: | Cancer Medicine |
Online Access: | https://doi.org/10.1002/cam4.5271 |
Similar Items
-
Transcriptomic changes in liver transplant recipients with non-alcoholic steatohepatitis indicate dysregulation of wound healing
by: Diogo Pellegrina, et al.
Published: (2023-05-01) -
An Unusual Cause of Acute Pancreatitis in a Liver Transplant Recipient
by: Imran Nizamuddin, MD, et al.
Published: (2021-05-01) -
Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant Recipients
by: Mamatha Bhat, et al.
Published: (2017-01-01) -
Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
by: Christopher J. Mowry, MD, et al.
Published: (2021-12-01) -
Deep learning-based pathway-centric approach to characterize recurrent hepatocellular carcinoma after liver transplantation
by: Jeffrey To, et al.
Published: (2024-06-01)